Clal Biotechnology Industries Ltd (CBI) — Capital Reinvestment Ratio

Latest as of September 2020: 0.73x

Clal Biotechnology Industries Ltd (CBI) has a Capital Reinvestment Ratio of 0.73x as of September 2020, meaning it reinvests 1% of its operating cash flow (ILA1.10 Million) in capital expenditures (ILA806.00K). See CBI equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.73x

Capex / Operating Cash Flow

Operating Cash Flow

ILA1.10 Million

ILA

Capital Expenditures

ILA806.00K

ILA

Data as of

Sep 2020

Most recent filing

Clal Biotechnology Industries Ltd Capital Reinvestment Ratio (2019–2019)

This chart tracks Clal Biotechnology Industries Ltd's Capital Reinvestment Ratio across 1 annual periods. Check Clal Biotechnology Industries Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Clal Biotechnology Industries Ltd (2019–2019)

Year-by-year Capital Reinvestment Ratio for Clal Biotechnology Industries Ltd from 2019 to 2019. For live market cap and broader valuation context, see Clal Biotechnology Industries Ltd (CBI) market capitalisation.

Year	Reinvestment Ratio	Operating CF (ILA)	Capital Expenditures	YoY Change
2019	0.10x	ILA27.03 Million	ILA2.83 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow